Cholesterol Drug Fenofibrate Reduces Risk of Amputation in Diabetics

Published: May 22, 2009

AP -- Doctors who gave diabetics a drug originally intended to lower patients' cholesterol found it reduced their risk of so-called minor amputation by 36 percent, a new analysis of research says. Researchers in Australia, Finland and New Zealand studied almost 10,000 patients aged 50 to 75 with type 2 diabetes, the kind linked to obesity.

Back to news